Cardiff Oncology (CRDF) Return on Assets (2012 - 2026)

Cardiff Oncology has reported Return on Assets for 14 years, with the latest figure at 0.02% in Q4 2025.

• Quarterly Return on Assets fell 1.0% year-over-year to 0.02% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.02% (down 1.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Assets declined to 0.02% in Q4 2025 per CRDF's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Assets peaked at 0.0% in Q1 2021 and troughed at 0.02% in Q4 2025.
• A 5-year average of 0.01% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
• The sharpest annual moves came in 2021 and 2023: Return on Assets rose 1 bps in 2021, then decreased 1 bps in 2023.
• Over 5 years, Return on Assets stood at 0.0% in 2021, then fell by 4 bps to 0.0% in 2022, then tumbled by 149 bps to 0.01% in 2023, then climbed by 2 bps to 0.01% in 2024, then tumbled by 84 bps to 0.02% in 2025.
• According to Business Quant data, Return on Assets over the past three periods registered 0.02%, 0.01%, and 0.01% for Q4 2025, Q3 2025, and Q2 2025 respectively.